Skip to main content

Table 2 Estimated cost (US $) per patient throughout the 6 months trial

From: Health economic evaluation alongside randomised clinical trial of a health behaviour intervention to manage type 2 diabetes in Nepal

Measurements

Intervention (n = 238)

Control (n = 243)

Mean differences (95% CI)

Mean

SD

Mean

SD

Direct medical costs

 Medical consultation

4.16

6.28

3.85

7.05

0.31 (-0.87 to 1.49)

 Screening

14.31

6.12

13.43

5.88

0.89 (-0.19 to 1.97)

 Medication

9.35

17.73

3.68

8.40

5.66 (3.23 to 8.10)

 Inpatient services

2.80

30.47

1.45

4.68

1.97 (-1.95 to 5.88)

 Sub-total

30.62

60.60

22.41

26.01

8.83 (3.82 to 13.84)

Direct non-medical costs

 Transportation

0.64

0.77

0.66

0.68

-0.02 (-0.15 to 0.11)

 Recommended food items

1.62

2.18

2.06

2.11

-0.43 (-0.80 to -0.05)

 Sub-total

2.27

2.95

2.71

2.79

-0.45 (-0.84 to -0.05)

Indirect costs

 Patient income loss

12.83

24.88

9.11

6.55

3.81 (0.55 to 7.06)

Intervention cost

 Phone call

0.47

0.08

na

na

na

 Peer support

2.53

1.37

na

na

na

 Intensive training

14.33

7.27

na

na

na

Total intervention cost

17.33

8.60

na

na

na

Total costs

63.03

59.57

34.23

17.08

28.80 (20.98 to 36.62)

  1. CIs were obtained from 10,000 bootstrap resampling technique using generalised linear model (GLM)
  2. na Not applicable, CI Confident intervals, SD Standard deviation